Latest filing published 03 Mar 2021 for Elanco Animal Health Inc, €22k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +9.8%Entry US$25.62 · Close at T+365 US$28.14
- -27.1%Entry US$36.19 · Close at T+365 US$26.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael-Bryant Hicks: trading record in brief
This profile gathers the share dealings of Michael-Bryant Hicks across 3 companies, led by Elanco Animal Health Inc, ModivCare Inc and Mallinckrodt plc. Between 7 March 2014 and 2 March 2021, the trades on record add up to 23 filings.
On the open market, the record shows 5 purchases worth €544k and 2 sales worth €54k. Netting one side against the other leaves €490k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 16 share grants.
A typical purchase (the median) is worth €102k. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 3 March 2021, reports a share grant of €22k in Elanco Animal Health Inc. The latest purchase dates back some time: it was published 2,632 days ago, on 26 August 2019. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael-Bryant Hicks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 799 shares@ US$33.653.7% of flowCommon StockSEC:0000950138-21-000178:0
- 880 shares@ US$32.344.0% of flowCommon StockSEC:0000950138-21-000178:1
- 6,533 shares@ US$30.5827.6% of flowCommon StockSEC:0000950138-21-000143:1
- 21,663 shares0Common StockSEC:0000950138-21-000143:0
- 799 shares@ US$27.407.0% of flowCommon StockSEC:0000950138-20-000120:0
- 9,000 shares0Common StockSEC:0000950138-20-000120:1
- 11,030 shares@ US$26.6568.5% of flowCommon StockSEC:0000950138-19-000470:0Canonical exit: 20 Nov 2019 (T+90)
- 8,181 shares0Common StockSEC:0000950138-19-000110:0
- 9,725 shares0Common StockSEC:0000950138-18-000566:0
- 5,000 shares@ US$24.0026.4% of flowCommon StockSEC:0001140361-18-039142:0Canonical exit: 23 Dec 2018 (T+90)
- 467 shares@ US$23.515.2% of flowOrdinary SharesSEC:0000950138-18-000059:0
- 7,900 shares@ US$20.8080.8% of flowOrdinary SharesSEC:0000950138-17-000748:0Canonical exit: 7 Feb 2018 (T+90)
- 260 shares@ US$44.576.2% of flowOrdinary SharesSEC:0000950138-17-000355:0
- 290 shares@ US$50.357.9% of flowOrdinary SharesSEC:0000950138-17-000290:0Canonical exit: 5 Jun 2017 (T+90)
- 4,833 shares0Ordinary SharesSEC:0000950138-17-000016:0
- 3,110 shares0Ordinary SharesSEC:0001445064-16-000239:0
- 396 shares@ US$46.67100.0% of flowCommon StockSEC:0001437749-16-026185:0
- 689 shares@ US$50.73Common StockSEC:0001181431-15-005008:0
- 1,211 shares0Common StockSEC:0001181431-15-004941:0
- 463 shares@ US$51.00Common StockSEC:0001181431-15-004941:1
- 253 shares@ US$44.56Common StockSEC:0001181431-15-004444:0
- 689 shares@ US$42.00Common StockSEC:0001181431-14-016046:0Canonical exit: 9 Jul 2014 (T+90)
- 2,147 shares0Common StockSEC:0001181431-14-012166:0
23 of 23 declarations
